Shortages of tirzepatide, sold as a diabetes drug (Mounjaro) and a weight-loss medication (Zepbound), have fueled demand for compounding pharmacies to make their own versions of the medicine, ...
Eli Lilly's tirzepatide, sold as Zepbound for weightloss and Mounjaro to treat diabetes, has been in short supply since 2022 amid skyrocketing demand. The medication is part of the ...
Mounjaro, the brand name for tirzepatide, is a drug that is used to treat type 2 diabetes by lowering blood sugar levels. It is approved for weightloss in the UK, however Ozempic isn’t ...